[Federal Register Volume 76, Number 125 (Wednesday, June 29, 2011)]
[Notices]
[Page 38122]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-16291]



[[Page 38122]]

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability for Exclusive, Non-Exclusive, or 
Partially-Exclusive Licensing of an Invention Concerning the 
Guanidylimidazole and Guanidylimidazoline Derivatives as Antimalarial 
Agents, Synthesis of and Methods of Use Thereof

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Provisional Patent Application Serial No. 
61/517,858, entitled ``Guanidylimidazole and Guanidylimidazoline 
Derivatives as Antimalarial Agents, Synthesis of and Methods of Use 
Thereof,'' filed on April 26, 2011. The United States Government, as 
represented by the Secretary of the Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
Attn: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to new 
guanidylimidazole derivatives and guanidylimidazoline derivatives, 
methods of making these compounds, compositions containing the same, 
and methods of using the same to prevent, treat, or inhibit malaria in 
a subject. The compounds have radical curative antimalarial activity.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2011-16291 Filed 6-28-11; 8:45 am]
BILLING CODE 3710-08-P